“There’s strong demand from investors for Nakamoto. We raised this additional funding in less than 72 hours, providing more working capital while continuing to acquire Bitcoin,” remarked David Bailey, Founder and CEO of Nakamoto. “We remain committed to our strategy of securing maximum capital to acquire as much Bitcoin as we can.”
The transaction encompasses
Advisors
Cohen & Company Capital Markets (“CCM”), part of J.V.B. Financial Group, LLC, is the lead financial advisor for Nakamoto and is serving as the placement agent for the PIPE Financing. Reed Smith LLP acts as legal advisor to Nakamoto, while Brunson Chandler & Jones, PLLC is the legal advisor for KindlyMD.
About KindlyMD
KindlyMD is a healthcare company that prioritizes patient needs, aiming to redefine value-based care and integrate healthcare data services. Utilizing data analytics, KindlyMD promotes personalized and evidence-backed solutions to minimize opioid usage, accelerate health outcomes, and incorporate alternative medicine into treatment plans. It provides a holistic healthcare experience that merges traditional medical care with mental health and compliant alternative medicine strategies.
The specialty outpatient clinical services offered by KindlyMD are covered by Medicare, Medicaid, and various commercial insurance contracts, and are also available on a fee-for-service basis. To learn more, visit www.kindlymd.com.
About Nakamoto
Nakamoto is pioneering a Bitcoin treasury organization focused on developing a global portfolio of Bitcoin-based firms. With plans to form the first publicly traded conglomerate of Bitcoin companies, Nakamoto aims to support its treasury through Bitcoin acquisition, thereby creating a network of Bitcoin enterprises spanning finance, media, and advisory sectors. For further details, visit nakamoto.com.
Additional Information and Where to Find It
KindlyMD plans to file an information statement with the SEC regarding the merger and PIPE financing. Investors are encouraged to read this information statement, available through the SEC website at www.sec.gov and KindlyMD’s site under the “Investors” tab, as it provides vital details about KindlyMD, Nakamoto, and the associated risks.
Forward-Looking Statements
This release contains forward-looking statements concerning the expected activities and developments for Kindly MD and Nakamoto. Key terms indicative of these include “estimate,” “anticipate,” “plan,” and similar variations. However, the absence of these terms does not exclude other statements from being considered forward-looking. Actual results may significantly differ due to various factors, including integration challenges and regulatory approvals, thus readers should not unduly rely on these forecasts.
